Trinity Biotech
TRIB
19 hedge funds and large institutions have $5.95M invested in Trinity Biotech in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 12 closing their positions.
130% more capital invested
Capital invested by funds: $2.59M → $5.95M (+$3.37M)
0.76% more ownership
Funds ownership: 0.79% → 1.55% (+0.76%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
27% less funds holding
Funds holding: 26 → 19 (-7)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
86% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$4.22M |
| 2 |
MAWA
Moss Adams Wealth Advisors
Seattle,
Washington
|
+$60.1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$31.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12.1K |
| 5 |
GRP
Global Retirement Partners
San Rafael,
California
|
+$1.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonehill Capital Management
New York
|
-$127K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$48.5K |
| 3 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
-$17.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$13.9K |
| 5 |
AC
Aristides Capital
Louisville,
Kentucky
|
-$12K |
TRIB Hedge Fund Activity: Q1 2024 in Review
19 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q1 2024, worth a combined $5.95M — up 130% from $2.59M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TRIB and 6 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 1 added.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $4.22M. The largest seller was Stonehill Capital Management, cutting an estimated $127K.
- 19 institutional investors held Trinity Biotech (TRIB) as of Q1 2024, down from 26 in Q4 2023.
- Funds reported $5.95M of Trinity Biotech stock for Q1 2024, up 130% quarter-over-quarter.
- 6 funds opened new Trinity Biotech positions in Q1 2024 and 12 closed out, a net change of -6 holders.
- The largest Trinity Biotech buyer in Q1 2024 was Perceptive Advisors, an estimated $4.22M added.
- The largest Trinity Biotech seller in Q1 2024 was Stonehill Capital Management, an estimated $127K sold.
Based on aggregated 13F filings for Q1 2024.